Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

China Pharma Holdings Inc Engages Arshak Davtyan, CPA As Independent Registered Public Accountant-Form 8-K


Tuesday, 15 Oct 2013 09:35am EDT 

China Pharma Holdings Inc reported in its Form 8-K that effective October 10, 2013, the Audit Committee of the Company engaged Arshak Davtyan, CPA (Davtyan) as the Company’s independent registered public accountant to provide audit services for the fiscal year ended December 31, 2013 and to review the financial statements for the interim period ended September 30, 2013. 

Latest Developments for China Pharma Holdings Inc

Company Quote

0.39
-0.029 -6.92%
4 Mar 2015